Literature DB >> 17226009

[History and definition(s) of metabolic syndrome].

M Hanefeld1, F Schaper, A Ceriello.   

Abstract

Metabolic syndrome--a cluster of metabolic diseases and hypertension--is not a new disease. It has been present in the upper classes of all highly developed cultures suffering from over-nutrition and limited physical activity. In the medical literature, it can be found in Renaissance and Baroque times. We are presently experiencing a global tsunami of this syndrome as over-nutrition and lack of movement are typical for large groups of the population. The current definition of metabolic syndrome of the American Heart Association/National Heart, Lung and Blood Institute and the International Diabetes Federation incorporates the quartet central obesity, hypertension, increased blood sugar and dyslipidemia (hypertriglyceridemia, low HDL cholesterol). Thus, simple, collective diagnostics and therapy for this finely meshed group of diseases together with its risk factors is possible.

Entities:  

Mesh:

Year:  2007        PMID: 17226009     DOI: 10.1007/s00108-006-1786-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

Review 3.  Abdominal obesity and the development of noninsulin-dependent diabetes mellitus.

Authors:  P Björntorp
Journal:  Diabetes Metab Rev       Date:  1988-09

4.  Prospective analysis of the insulin-resistance syndrome (syndrome X).

Authors:  S M Haffner; R A Valdez; H P Hazuda; B D Mitchell; P A Morales; M P Stern
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

5.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

Review 6.  Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

Authors:  R A DeFronzo; E Ferrannini
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

Review 7.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Richard Kahn; John Buse; Ele Ferrannini; Michael Stern
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

8.  High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells.

Authors:  Narkunaraja Shanmugam; Marpadga A Reddy; Mausumee Guha; Rama Natarajan
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

9.  Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.

Authors:  J S Yudkin; I Juhan-Vague; E Hawe; S E Humphries; G di Minno; M Margaglione; E Tremoli; T Kooistra; P E Morange; P Lundman; V Mohamed-Ali; A Hamsten
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

Review 10.  Diabetes and cardiovascular disease. The "common soil" hypothesis.

Authors:  M P Stern
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

View more
  1 in total

1.  Metabolic syndrome and the plasma proteome: from association to causation.

Authors:  Mohamed A Elhadad; Rory Wilson; Shaza B Zaghlool; Cornelia Huth; Christian Gieger; Harald Grallert; Johannes Graumann; Wolfgang Rathmann; Wolfgang Koenig; Moritz F Sinner; Kristian Hveem; Karsten Suhre; Barbara Thorand; Christian Jonasson; Melanie Waldenberger; Annette Peters
Journal:  Cardiovasc Diabetol       Date:  2021-05-20       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.